Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cataract | 39 | 2024 | 834 | 7.630 |
Why?
|
Cataract Extraction | 30 | 2023 | 481 | 7.370 |
Why?
|
Retinopathy of Prematurity | 36 | 2023 | 421 | 7.090 |
Why?
|
Lens Implantation, Intraocular | 31 | 2022 | 192 | 6.900 |
Why?
|
Lenses, Intraocular | 18 | 2022 | 140 | 6.340 |
Why?
|
Aphakia, Postcataract | 18 | 2022 | 54 | 4.630 |
Why?
|
Glaucoma | 12 | 2023 | 1159 | 3.240 |
Why?
|
Aphakia | 6 | 2023 | 24 | 2.830 |
Why?
|
Hydrophthalmos | 3 | 2023 | 24 | 2.490 |
Why?
|
Glaucoma Drainage Implants | 3 | 2022 | 116 | 2.160 |
Why?
|
Refraction, Ocular | 9 | 2022 | 182 | 2.050 |
Why?
|
Retinal Neoplasms | 6 | 2015 | 144 | 1.920 |
Why?
|
Ophthalmology | 13 | 2021 | 508 | 1.900 |
Why?
|
Refractive Errors | 7 | 2022 | 142 | 1.850 |
Why?
|
Strabismus | 10 | 2022 | 287 | 1.760 |
Why?
|
Retinoblastoma | 5 | 2015 | 318 | 1.710 |
Why?
|
Myopia | 5 | 2022 | 254 | 1.690 |
Why?
|
Visual Acuity | 23 | 2022 | 2530 | 1.600 |
Why?
|
Optics and Photonics | 5 | 2022 | 321 | 1.570 |
Why?
|
Trabeculectomy | 2 | 2022 | 162 | 1.500 |
Why?
|
Academies and Institutes | 11 | 2021 | 317 | 1.460 |
Why?
|
Intraocular Pressure | 12 | 2023 | 1274 | 1.450 |
Why?
|
Amblyopia | 3 | 2022 | 143 | 1.360 |
Why?
|
Contact Lenses | 4 | 2019 | 145 | 1.330 |
Why?
|
Phacoemulsification | 3 | 2022 | 149 | 1.290 |
Why?
|
Pseudophakia | 8 | 2022 | 62 | 1.200 |
Why?
|
Xanthomatosis, Cerebrotendinous | 2 | 2024 | 9 | 1.170 |
Why?
|
Infant, Newborn | 54 | 2023 | 25618 | 0.960 |
Why?
|
Persistent Hyperplastic Primary Vitreous | 1 | 2023 | 7 | 0.940 |
Why?
|
Eye Abnormalities | 2 | 2023 | 246 | 0.870 |
Why?
|
Infant | 52 | 2023 | 35129 | 0.820 |
Why?
|
Child | 44 | 2023 | 77679 | 0.790 |
Why?
|
Angiogenesis Inhibitors | 7 | 2023 | 2038 | 0.740 |
Why?
|
Child, Preschool | 37 | 2023 | 40992 | 0.730 |
Why?
|
Biometry | 6 | 2023 | 558 | 0.720 |
Why?
|
Lens Capsule, Crystalline | 1 | 2019 | 43 | 0.690 |
Why?
|
Eye Diseases | 4 | 2016 | 668 | 0.680 |
Why?
|
Orthokeratologic Procedures | 1 | 2018 | 6 | 0.680 |
Why?
|
Technology Assessment, Biomedical | 7 | 2021 | 307 | 0.660 |
Why?
|
Gestational Age | 22 | 2023 | 3493 | 0.650 |
Why?
|
Lens, Crystalline | 3 | 2020 | 388 | 0.650 |
Why?
|
Infant, Premature, Diseases | 2 | 2021 | 706 | 0.620 |
Why?
|
Vascular Endothelial Growth Factor A | 5 | 2019 | 3506 | 0.620 |
Why?
|
Eyeglasses | 1 | 2019 | 145 | 0.610 |
Why?
|
Vision, Low | 1 | 2020 | 168 | 0.610 |
Why?
|
Vision Disorders | 5 | 2022 | 1059 | 0.610 |
Why?
|
Optic Disk | 1 | 2021 | 401 | 0.590 |
Why?
|
Eye Injuries | 1 | 2020 | 245 | 0.580 |
Why?
|
Retinal Diseases | 2 | 2021 | 683 | 0.580 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 2 | 2020 | 664 | 0.570 |
Why?
|
Ectopia Lentis | 2 | 2013 | 20 | 0.560 |
Why?
|
Neonatal Screening | 4 | 2020 | 591 | 0.560 |
Why?
|
Dacryocystorhinostomy | 3 | 2008 | 72 | 0.540 |
Why?
|
Laser Coagulation | 6 | 2023 | 326 | 0.540 |
Why?
|
Infant, Premature | 14 | 2023 | 2044 | 0.530 |
Why?
|
Photography | 2 | 2010 | 520 | 0.520 |
Why?
|
Melphalan | 2 | 2014 | 431 | 0.510 |
Why?
|
Intravitreal Injections | 7 | 2023 | 345 | 0.510 |
Why?
|
Humans | 119 | 2024 | 744220 | 0.510 |
Why?
|
Neuroectodermal Tumors, Primitive | 2 | 2014 | 140 | 0.500 |
Why?
|
Nasolacrimal Duct | 2 | 2008 | 74 | 0.500 |
Why?
|
Pupil Disorders | 1 | 2014 | 33 | 0.490 |
Why?
|
Infusions, Intra-Arterial | 1 | 2014 | 231 | 0.480 |
Why?
|
Postoperative Complications | 10 | 2021 | 15294 | 0.460 |
Why?
|
Corneal Endothelial Cell Loss | 1 | 2013 | 24 | 0.460 |
Why?
|
Retrospective Studies | 34 | 2023 | 77426 | 0.450 |
Why?
|
Retinal Vessels | 2 | 2016 | 772 | 0.440 |
Why?
|
Glaucoma, Open-Angle | 1 | 2019 | 711 | 0.440 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2014 | 627 | 0.430 |
Why?
|
Diagnostic Techniques, Ophthalmological | 2 | 2016 | 245 | 0.430 |
Why?
|
gamma-Crystallins | 1 | 2011 | 9 | 0.420 |
Why?
|
Nystagmus, Pathologic | 1 | 2012 | 96 | 0.420 |
Why?
|
Hyperopia | 1 | 2012 | 44 | 0.420 |
Why?
|
Weight Gain | 4 | 2021 | 2292 | 0.410 |
Why?
|
Ophthalmologic Surgical Procedures | 3 | 2021 | 349 | 0.410 |
Why?
|
Mydriatics | 4 | 2022 | 68 | 0.390 |
Why?
|
Endothelium, Corneal | 1 | 2013 | 199 | 0.390 |
Why?
|
Propoxycaine | 1 | 2010 | 6 | 0.370 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2013 | 347 | 0.370 |
Why?
|
Follow-Up Studies | 19 | 2023 | 39045 | 0.360 |
Why?
|
Lasers, Semiconductor | 1 | 2010 | 46 | 0.360 |
Why?
|
Benchmarking | 1 | 2016 | 1042 | 0.360 |
Why?
|
Eye Neoplasms | 1 | 2012 | 313 | 0.360 |
Why?
|
Axial Length, Eye | 2 | 2023 | 31 | 0.350 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2013 | 601 | 0.340 |
Why?
|
Infant, Very Low Birth Weight | 7 | 2016 | 406 | 0.340 |
Why?
|
Anterior Eye Segment | 1 | 2010 | 152 | 0.330 |
Why?
|
Schools | 1 | 2017 | 1433 | 0.330 |
Why?
|
Retinoscopy | 3 | 2020 | 27 | 0.330 |
Why?
|
Mucocele | 1 | 2008 | 49 | 0.330 |
Why?
|
Optic Nerve Neoplasms | 1 | 2008 | 44 | 0.320 |
Why?
|
Birth Weight | 5 | 2023 | 2069 | 0.320 |
Why?
|
Hemangioma | 1 | 2013 | 737 | 0.320 |
Why?
|
Eye | 3 | 2022 | 729 | 0.310 |
Why?
|
Fluprednisolone | 2 | 2016 | 6 | 0.290 |
Why?
|
Treatment Outcome | 19 | 2023 | 63119 | 0.290 |
Why?
|
Atropine | 2 | 2017 | 244 | 0.290 |
Why?
|
Endoscopy | 3 | 2008 | 1784 | 0.280 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 3227 | 0.280 |
Why?
|
Quality Indicators, Health Care | 1 | 2016 | 1831 | 0.280 |
Why?
|
Communication | 1 | 2020 | 3749 | 0.270 |
Why?
|
Prosthesis Implantation | 2 | 2021 | 642 | 0.270 |
Why?
|
Female | 53 | 2023 | 380197 | 0.260 |
Why?
|
Prednisolone | 2 | 2016 | 334 | 0.260 |
Why?
|
Suture Techniques | 2 | 2021 | 798 | 0.260 |
Why?
|
Oxygen | 3 | 2021 | 4187 | 0.250 |
Why?
|
Male | 50 | 2023 | 350027 | 0.240 |
Why?
|
Cornea | 2 | 2023 | 1524 | 0.240 |
Why?
|
Cholestanol | 1 | 2023 | 4 | 0.230 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2006 | 367 | 0.230 |
Why?
|
Neurofibromatosis 1 | 1 | 2008 | 568 | 0.230 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 3328 | 0.220 |
Why?
|
Mutation, Missense | 1 | 2011 | 2563 | 0.210 |
Why?
|
Hearing Loss, Sensorineural | 2 | 2020 | 770 | 0.210 |
Why?
|
Soft Tissue Neoplasms | 1 | 2012 | 1363 | 0.210 |
Why?
|
Risk Factors | 17 | 2023 | 72280 | 0.210 |
Why?
|
Insulin-Like Growth Factor I | 5 | 2019 | 2014 | 0.210 |
Why?
|
Exotropia | 1 | 2022 | 55 | 0.200 |
Why?
|
Lacrimal Duct Obstruction | 3 | 2008 | 48 | 0.200 |
Why?
|
Vision, Binocular | 2 | 2021 | 213 | 0.200 |
Why?
|
Esotropia | 1 | 2022 | 91 | 0.200 |
Why?
|
Bile Acids and Salts | 1 | 2023 | 363 | 0.190 |
Why?
|
Wolfram Syndrome | 1 | 2020 | 13 | 0.190 |
Why?
|
Ophthalmoscopy | 2 | 2014 | 176 | 0.190 |
Why?
|
Pain Measurement | 1 | 2010 | 3419 | 0.180 |
Why?
|
Inflammation | 5 | 2021 | 10634 | 0.180 |
Why?
|
Oxygen Consumption | 1 | 2006 | 1869 | 0.180 |
Why?
|
Adolescent | 12 | 2023 | 85759 | 0.180 |
Why?
|
Eye Diseases, Hereditary | 1 | 2021 | 117 | 0.180 |
Why?
|
Retinal Rod Photoreceptor Cells | 1 | 2001 | 195 | 0.170 |
Why?
|
Prosthesis Design | 2 | 2020 | 2110 | 0.170 |
Why?
|
Nerve Growth Factors | 2 | 2019 | 576 | 0.170 |
Why?
|
Angiogenic Proteins | 1 | 2019 | 104 | 0.170 |
Why?
|
Lens Subluxation | 1 | 2018 | 20 | 0.170 |
Why?
|
Placental Insufficiency | 1 | 2019 | 51 | 0.170 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2019 | 123 | 0.160 |
Why?
|
Vitrectomy | 2 | 2018 | 365 | 0.160 |
Why?
|
Hemangioma, Capillary | 1 | 2018 | 61 | 0.160 |
Why?
|
Colorado | 1 | 2018 | 163 | 0.160 |
Why?
|
Iris | 1 | 2019 | 239 | 0.160 |
Why?
|
Sclera | 1 | 2019 | 200 | 0.160 |
Why?
|
Tomography, Optical Coherence | 2 | 2021 | 2657 | 0.150 |
Why?
|
Oculomotor Muscles | 1 | 2021 | 371 | 0.150 |
Why?
|
Infant, Extremely Low Birth Weight | 3 | 2019 | 89 | 0.150 |
Why?
|
Aptamers, Nucleotide | 1 | 2019 | 166 | 0.150 |
Why?
|
Artificial Intelligence | 2 | 2021 | 2213 | 0.150 |
Why?
|
Ophthalmic Solutions | 3 | 2016 | 317 | 0.150 |
Why?
|
Prospective Studies | 11 | 2023 | 53280 | 0.150 |
Why?
|
Eyelid Neoplasms | 1 | 2018 | 94 | 0.150 |
Why?
|
Epinephrine | 1 | 2020 | 793 | 0.140 |
Why?
|
Rubella Syndrome, Congenital | 1 | 2016 | 12 | 0.140 |
Why?
|
Propranolol | 1 | 2018 | 502 | 0.140 |
Why?
|
Placenta | 2 | 2019 | 1697 | 0.140 |
Why?
|
Marfan Syndrome | 1 | 2018 | 240 | 0.140 |
Why?
|
Sensory Deprivation | 1 | 2016 | 109 | 0.140 |
Why?
|
Retinal Vein Occlusion | 1 | 1997 | 137 | 0.140 |
Why?
|
Telemedicine | 3 | 2020 | 2872 | 0.140 |
Why?
|
Orbital Neoplasms | 1 | 2018 | 225 | 0.140 |
Why?
|
Uveitis, Anterior | 1 | 2016 | 101 | 0.140 |
Why?
|
Blepharoptosis | 1 | 2016 | 144 | 0.130 |
Why?
|
CpG Islands | 1 | 2019 | 1172 | 0.130 |
Why?
|
Fetal Growth Retardation | 2 | 2019 | 570 | 0.130 |
Why?
|
Disabled Children | 1 | 2017 | 247 | 0.130 |
Why?
|
Genes, Retinoblastoma | 1 | 2015 | 136 | 0.130 |
Why?
|
Blue Toe Syndrome | 1 | 2014 | 4 | 0.120 |
Why?
|
United States | 13 | 2021 | 69867 | 0.120 |
Why?
|
Eye Enucleation | 1 | 2014 | 128 | 0.120 |
Why?
|
Nigeria | 1 | 2017 | 733 | 0.120 |
Why?
|
Prevalence | 3 | 2023 | 15226 | 0.120 |
Why?
|
Ophthalmic Artery | 1 | 2014 | 60 | 0.120 |
Why?
|
Eye Proteins | 1 | 2017 | 646 | 0.120 |
Why?
|
Skin Neoplasms | 1 | 2013 | 5670 | 0.120 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2019 | 1676 | 0.120 |
Why?
|
Ciliary Body | 1 | 2014 | 173 | 0.120 |
Why?
|
Injections, Intra-Arterial | 1 | 2013 | 193 | 0.120 |
Why?
|
Emmetropia | 1 | 2013 | 6 | 0.120 |
Why?
|
Glioma | 1 | 2008 | 3401 | 0.110 |
Why?
|
Infant, Low Birth Weight | 1 | 2018 | 850 | 0.110 |
Why?
|
Connective Tissue Diseases | 1 | 2016 | 264 | 0.110 |
Why?
|
Astigmatism | 1 | 2013 | 69 | 0.110 |
Why?
|
Eyelid Diseases | 1 | 2014 | 155 | 0.110 |
Why?
|
Mitochondrial Diseases | 1 | 2016 | 321 | 0.110 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2018 | 1240 | 0.110 |
Why?
|
Retinal Vein | 2 | 2005 | 47 | 0.110 |
Why?
|
Retinal Detachment | 1 | 2016 | 411 | 0.100 |
Why?
|
Refractometry | 1 | 2012 | 56 | 0.100 |
Why?
|
Reproducibility of Results | 6 | 2020 | 19907 | 0.100 |
Why?
|
Cell Shape | 1 | 2013 | 375 | 0.100 |
Why?
|
Tuberous Sclerosis | 1 | 2020 | 1029 | 0.100 |
Why?
|
Topotecan | 1 | 2012 | 138 | 0.100 |
Why?
|
Uveal Neoplasms | 1 | 2014 | 310 | 0.100 |
Why?
|
Odds Ratio | 4 | 2019 | 9849 | 0.100 |
Why?
|
Endophthalmitis | 1 | 2014 | 262 | 0.100 |
Why?
|
Pedigree | 3 | 2024 | 4648 | 0.100 |
Why?
|
Algorithms | 5 | 2021 | 13885 | 0.100 |
Why?
|
Antineoplastic Agents | 1 | 2014 | 13668 | 0.100 |
Why?
|
Time Factors | 4 | 2021 | 40063 | 0.100 |
Why?
|
Databases, Factual | 4 | 2019 | 7730 | 0.100 |
Why?
|
Arthritis | 1 | 2016 | 659 | 0.090 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2011 | 326 | 0.090 |
Why?
|
Logistic Models | 3 | 2015 | 13409 | 0.090 |
Why?
|
Catheterization, Peripheral | 1 | 2014 | 344 | 0.090 |
Why?
|
Electroretinography | 2 | 2023 | 509 | 0.090 |
Why?
|
Hyphema | 1 | 2010 | 26 | 0.090 |
Why?
|
Recombinant Fusion Proteins | 1 | 2019 | 3772 | 0.090 |
Why?
|
Epidermolysis Bullosa Dystrophica | 1 | 2010 | 26 | 0.090 |
Why?
|
Chorioamnionitis | 1 | 2011 | 155 | 0.090 |
Why?
|
Fixation, Ocular | 1 | 2011 | 251 | 0.090 |
Why?
|
Orbital Cellulitis | 1 | 2010 | 33 | 0.090 |
Why?
|
Retinal Neovascularization | 1 | 2012 | 244 | 0.090 |
Why?
|
Vincristine | 1 | 2012 | 1036 | 0.090 |
Why?
|
Incidence | 4 | 2021 | 20945 | 0.090 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 25043 | 0.090 |
Why?
|
Early Diagnosis | 1 | 2014 | 1184 | 0.090 |
Why?
|
Health Services Needs and Demand | 1 | 2017 | 1411 | 0.090 |
Why?
|
Disease Progression | 3 | 2018 | 13280 | 0.080 |
Why?
|
Mutation | 4 | 2020 | 29784 | 0.080 |
Why?
|
Skin Ulcer | 1 | 2010 | 120 | 0.080 |
Why?
|
Cell Count | 1 | 2013 | 1854 | 0.080 |
Why?
|
Genes, Dominant | 1 | 2011 | 880 | 0.080 |
Why?
|
Monitoring, Physiologic | 1 | 2016 | 1737 | 0.080 |
Why?
|
Ocular Hypertension | 1 | 2010 | 198 | 0.080 |
Why?
|
False Positive Reactions | 2 | 2012 | 981 | 0.080 |
Why?
|
Massachusetts | 1 | 2021 | 8663 | 0.080 |
Why?
|
Microscopy | 1 | 2013 | 903 | 0.080 |
Why?
|
Remote Consultation | 1 | 2010 | 238 | 0.080 |
Why?
|
Corneal Diseases | 1 | 2014 | 636 | 0.080 |
Why?
|
Longitudinal Studies | 2 | 2022 | 13990 | 0.070 |
Why?
|
Fatal Outcome | 1 | 2012 | 1849 | 0.070 |
Why?
|
Eye Infections, Bacterial | 1 | 2010 | 235 | 0.070 |
Why?
|
Cellulitis | 1 | 2008 | 206 | 0.070 |
Why?
|
Glucocorticoids | 1 | 2016 | 2108 | 0.070 |
Why?
|
Autistic Disorder | 1 | 2016 | 1185 | 0.070 |
Why?
|
Young Adult | 3 | 2023 | 56436 | 0.070 |
Why?
|
Genetic Linkage | 1 | 2011 | 2422 | 0.070 |
Why?
|
Cyclophosphamide | 1 | 2012 | 2236 | 0.070 |
Why?
|
Carbon Dioxide | 1 | 2010 | 1147 | 0.070 |
Why?
|
Risk Assessment | 3 | 2021 | 23337 | 0.070 |
Why?
|
Face | 1 | 2012 | 994 | 0.070 |
Why?
|
Psychomotor Performance | 1 | 2014 | 1901 | 0.070 |
Why?
|
Pregnancy | 7 | 2019 | 29142 | 0.070 |
Why?
|
Doxorubicin | 1 | 2012 | 2220 | 0.070 |
Why?
|
Predictive Value of Tests | 3 | 2012 | 15070 | 0.060 |
Why?
|
DNA Methylation | 1 | 2019 | 4289 | 0.060 |
Why?
|
Retinal Artery | 1 | 2005 | 111 | 0.060 |
Why?
|
Heterozygote | 1 | 2011 | 2805 | 0.060 |
Why?
|
Brain Diseases | 1 | 2014 | 1564 | 0.060 |
Why?
|
Nutritional Status | 1 | 2013 | 1609 | 0.060 |
Why?
|
Cross-Over Studies | 1 | 2010 | 2032 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3611 | 0.060 |
Why?
|
Body Weight | 1 | 2015 | 4666 | 0.060 |
Why?
|
Double-Blind Method | 3 | 2016 | 12035 | 0.060 |
Why?
|
Craniofacial Abnormalities | 1 | 2007 | 315 | 0.060 |
Why?
|
Child Development | 1 | 2015 | 2223 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2020 | 7879 | 0.060 |
Why?
|
Pediatrics | 1 | 2018 | 3469 | 0.060 |
Why?
|
Oximetry | 1 | 2006 | 469 | 0.060 |
Why?
|
Risk | 1 | 2015 | 9685 | 0.060 |
Why?
|
Anesthetics, Local | 1 | 2010 | 985 | 0.060 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2015 | 2408 | 0.060 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4188 | 0.050 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2010 | 1537 | 0.050 |
Why?
|
Social Conditions | 1 | 2023 | 126 | 0.050 |
Why?
|
Equipment Design | 1 | 2010 | 3582 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5755 | 0.050 |
Why?
|
Regression Analysis | 1 | 2011 | 6461 | 0.050 |
Why?
|
Adult | 7 | 2023 | 214035 | 0.050 |
Why?
|
Sensitivity and Specificity | 4 | 2015 | 14726 | 0.050 |
Why?
|
Surgical Flaps | 1 | 2010 | 1640 | 0.050 |
Why?
|
Registries | 3 | 2023 | 8090 | 0.050 |
Why?
|
Nervous System Diseases | 1 | 2011 | 1623 | 0.050 |
Why?
|
Treatment Failure | 1 | 2007 | 2619 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8387 | 0.050 |
Why?
|
Heart Defects, Congenital | 1 | 1997 | 4586 | 0.050 |
Why?
|
Ultrasonography, Prenatal | 1 | 2008 | 1695 | 0.050 |
Why?
|
Syndrome | 1 | 2007 | 3250 | 0.050 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2005 | 720 | 0.050 |
Why?
|
Intensive Care Units, Neonatal | 2 | 2020 | 780 | 0.050 |
Why?
|
Base Sequence | 1 | 2011 | 12801 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11007 | 0.050 |
Why?
|
Dark Adaptation | 1 | 2001 | 219 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2017 | 5138 | 0.050 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2011 | 2026 | 0.040 |
Why?
|
Sensory Thresholds | 1 | 2001 | 394 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2014 | 35423 | 0.040 |
Why?
|
Crystallins | 1 | 1999 | 75 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12961 | 0.040 |
Why?
|
Models, Biological | 1 | 2016 | 9582 | 0.040 |
Why?
|
Sutures | 1 | 2021 | 299 | 0.040 |
Why?
|
Vision Tests | 1 | 2019 | 167 | 0.040 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 1999 | 335 | 0.040 |
Why?
|
Lasers | 1 | 2023 | 952 | 0.040 |
Why?
|
Molecular Sequence Data | 1 | 2011 | 18116 | 0.040 |
Why?
|
Acute Disease | 2 | 2016 | 7148 | 0.040 |
Why?
|
Anterior Chamber | 1 | 2018 | 197 | 0.040 |
Why?
|
Genes, Recessive | 1 | 2020 | 643 | 0.040 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1999 | 768 | 0.040 |
Why?
|
Glaucoma, Neovascular | 1 | 1997 | 36 | 0.040 |
Why?
|
Aged, 80 and over | 1 | 2022 | 57768 | 0.040 |
Why?
|
Cognition | 1 | 2014 | 6765 | 0.040 |
Why?
|
Age of Onset | 2 | 2020 | 3270 | 0.040 |
Why?
|
Retina | 2 | 2020 | 2616 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10949 | 0.030 |
Why?
|
Safety | 1 | 2001 | 1185 | 0.030 |
Why?
|
Fundus Oculi | 1 | 1997 | 473 | 0.030 |
Why?
|
Depth Perception | 1 | 2016 | 94 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 1999 | 1246 | 0.030 |
Why?
|
Pain | 1 | 2010 | 4987 | 0.030 |
Why?
|
Coloboma | 1 | 2014 | 54 | 0.030 |
Why?
|
Administration, Topical | 1 | 2016 | 689 | 0.030 |
Why?
|
ROC Curve | 2 | 2016 | 3527 | 0.030 |
Why?
|
Antigens, Nuclear | 1 | 2014 | 192 | 0.030 |
Why?
|
S100 Proteins | 1 | 2014 | 259 | 0.030 |
Why?
|
Blood Proteins | 1 | 2019 | 1123 | 0.030 |
Why?
|
Cryotherapy | 1 | 2014 | 155 | 0.030 |
Why?
|
Point Mutation | 1 | 1999 | 1624 | 0.030 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2014 | 528 | 0.030 |
Why?
|
Intelligence Tests | 1 | 2014 | 505 | 0.030 |
Why?
|
Keratins | 1 | 2014 | 515 | 0.030 |
Why?
|
Life Tables | 1 | 2013 | 370 | 0.030 |
Why?
|
Choroid | 1 | 2014 | 322 | 0.030 |
Why?
|
Sweden | 1 | 2015 | 1345 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 15525 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2018 | 15538 | 0.030 |
Why?
|
Intraoperative Complications | 1 | 2019 | 1195 | 0.030 |
Why?
|
Reoperation | 1 | 2001 | 4203 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2024 | 3598 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 11493 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2014 | 1799 | 0.020 |
Why?
|
Genetic Testing | 1 | 2024 | 3443 | 0.020 |
Why?
|
Skin Care | 1 | 2010 | 49 | 0.020 |
Why?
|
Canada | 1 | 2015 | 2065 | 0.020 |
Why?
|
Mucin-1 | 1 | 2014 | 544 | 0.020 |
Why?
|
Cohort Studies | 2 | 2023 | 40559 | 0.020 |
Why?
|
Sentinel Surveillance | 1 | 2010 | 281 | 0.020 |
Why?
|
Eyelids | 1 | 2010 | 265 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 29050 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 1997 | 2047 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 1789 | 0.020 |
Why?
|
Maternal-Fetal Exchange | 1 | 2009 | 455 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2010 | 20123 | 0.020 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2009 | 546 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2010 | 2557 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2014 | 2422 | 0.020 |
Why?
|
Trans-Activators | 1 | 2014 | 2924 | 0.020 |
Why?
|
Erythropoietin | 1 | 2009 | 724 | 0.020 |
Why?
|
Cytokines | 1 | 2017 | 7326 | 0.010 |
Why?
|
Area Under Curve | 1 | 2005 | 1655 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2014 | 4465 | 0.010 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2009 | 1344 | 0.010 |
Why?
|
Nuclear Family | 1 | 1999 | 318 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2010 | 12244 | 0.010 |
Why?
|
Cattle | 1 | 1999 | 3922 | 0.010 |
Why?
|
Exons | 1 | 1999 | 2439 | 0.010 |
Why?
|
Diet | 1 | 2009 | 7937 | 0.010 |
Why?
|
Animals | 3 | 2009 | 168788 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 1999 | 6172 | 0.010 |
Why?
|
Models, Molecular | 1 | 1999 | 5458 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2005 | 8950 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 1999 | 4328 | 0.000 |
Why?
|
Brain | 1 | 2014 | 26413 | 0.000 |
Why?
|
Genotype | 1 | 1999 | 12956 | 0.000 |
Why?
|